Full Press Release Details
GAITHERSBURG, Md., Feb. 27, 2025 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), today announced that the management team will participate in the following upcoming investor conferences:
| TD Cowen 45 th Annual Health Care Conference: | ||
| Fireside Chat | ||
| Date: | Tuesday, March 4, 2025 | |
| Time: | 9:10 – 9:40 a.m. Eastern Time (ET) | |
| Location: | Boston, MA | |
| Conference | ||
| Event: | Investor Meetings | |
| Date: | Tuesday, March 4, 2025 | |
| Leerink Partners 2025 Global Healthcare Conference: | ||
| Presentation | ||
| Date: | Tuesday, March 11, 2025 | |
| Time: | 3:40 – 4:10 p.m. ET | |
| Location: | Miami Beach, FL | |
| Conference | ||
| Event: | Investor Meetings | |
| Date: | Tuesday, March 11, 2025 | |
| Jefferies Biotech on the Beach Summit: | ||
| Conference | ||
| Event: | Investor Meetings | |
| Date: | Wednesday, March 12, 2025 | |
| Location: | Miami Beach, FL |
A webcast of the fireside chat and presentation will be available through the Events and Presentations page of the Company's website at ir.novavax.com, with replays available for 30 days after the conferences.
Novavax, Inc. (Nasdaq: NVAX) tackles some of the world's most significant health challenges by leveraging its scientific expertise in vaccines and its cutting-edge technology platform, including a protein-based nanoparticle and Matrix-M™ adjuvant. The Company's growth strategy is focused on building new and diversified partnerships via the out-licensing of its technology platform and vaccine assets earlier in the development process. These strategic collaborations are fueled by smart investments in a growing early-stage pipeline starting with the Company's core expertise in infectious disease and potentially expanding into other disease areas. Please visit novavax.com and LinkedIn for more information.
SOURCE Novavax, Inc.
21 %
more press release views with